ADDS offers pharmaceutical, biotech and medtech companies full coverage of Phase II-III and late phase clinical studies for drugs and medical devices in Western and Central Europe through our offices in France and Czech Republic, as well as in Israel.
As a well-established high-quality European service provider, Advanced Drug and Device Services (ADDS) Group contributes to successfully bring as early, safely and cost effectively as possible your products to the market in a unique one-stop shop approach for Europe.
ADDS helps you to:
- Conceive your complete development program and risk management plan
- Secure your administrative submissions
- Select the right investigator sites
- Shorten the patient recruitment time
- Improve the patient retention ratio
- Anticipate the risks and solve the issues
- Provide high quality data and reports
- Meet the Regulatory requirements
Fields of expertise
- Drug development
- Oncology
- Central Nervous System (CNS) (eg Alzheimer, neurodenerative diseases, multiple sclerosis, psychiatry)
- Cardiovascular diseases and metabolism
- Orphan Drug
- Medical devices
- Combination Products
- Paediatric Investigation Plan
Description of services
- Consulting
- Phase II/III studies
- Late Phase studies, Phase IV
- Project Management
- Submissions
- Monitoring
- Data Management
- Statistics
- Medical Writing
- Safety
- Risk Management Plan
Geographical coverage
- Western Europe
- Central Europe
- Israel
- Middle East and North African Regions (MENA): Algeria, Morocco, Tunisia, Egypt,…